Our Press Releases
Article Category
Multiple sclerosis (MS)
Quick Review over Multiple sclerosis (MS) Multiple sclerosis (MS) is a lifelong, and often
Protein Tyrosine Kinases:Their Roles and Their Targeting in Leukemia
Protein tyrosine kinases superfamily definition A large group of enzymes that speeding up protein
Disease modifying therapies (DMTs)
Quick Review Over Disease Modifying Therapies (DMTs) For Multiple Sclerosis Introduction: Multiple sclerosis (MS)
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell
Type 2 Diabetes Mellitus
Overview of Type 2 Diabetes Mellitus Type 2 diabetes mellitus is the most common
Parsian Pharama Review of CDK4/6 Inhibitors Citing to the Recent Articles
Parsian pharama review of CDK4-6 inhibitors citing to the recent articles One of the
US FDA Approved Empagliflozin
The U.S. FDA Approved Empagliflozin for Wider Range of Patients with Heart Failure
Breaking news; U.S FDA advisory panel narrowly endorses Molnupiravir
Breaking news; U.S FDA advisory panel narrowly endorses Molnupiravir U.S FDA advisory panel
Aromatase Inhibitors
Parsian pharma review of aromatase inhibitors (AIs) citing to the recent articles regard this